SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

Clinical trial NCT06627712 · RECRUITING

Trial details

NCT number: NCT06627712
Sponsor: West China Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

TNBC - Triple-Negative Breast Cancer

Start date: 2024-11-01
Primary completion: 2029-11-01
Enrollment: 318

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.